Listed

Mativ Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2023

Filed with the SEC on Nov 9, 2023 and accepted by EDGAR at Nov 9, 2023, 16:55 ET.

Share

Management's discussion and analysis

As filed, 41,003 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is a discussion of our financial condition and results of operations. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this report and the audited consolidated financial statements and related notes and the selected financial data included in our Annual Report on Form 10-K for the year ended December 31, 2022. The discussion of our financial condition and results of operations includes various forward-looking statements about our markets, the demand for our products and our future prospects. These statements are based on certain assumptions we consider reasonable. For information about risks and exposures relating to us and our business, you should read the section entitled "Risk Factors" in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, the section entitled "Forward-Looking Statements" at the end of this Item 2 and the section entitled “Risk Factors” at Part II, Item 1A hereof. Unless the context indicates otherwise, references to "Mativ," "we," "us," "our," the "Company" or similar terms include Mativ Holdings, Inc. and our consolidated subsidiaries.

This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of our financial statements with an understanding of our recent performance, our financial condition and our prospects.

As discussed in Note 16. Discontinued Operations to the unaudited condensed consolidated financial statements, the results from continuing operations exclude the results of our EP Business for all periods presented. All information presented within this MD&A is on a continuing operations basis.

Merger

On July 6, 2022, the Company completed its previously announced merger with Neenah, Inc. ("Neenah") under the terms of an Agreement and Plan of Merger, pursuant to which a wholly-owned subsidiary merged with and into Neenah (the "Merger"), with Neenah surviving as a direct and wholly-owned subsidiary of the Company. Refer to Note 4. Business Acquisitions in the notes to the unaudited condensed consolidated financial statements for further information related to the Merger. Refer to Note 15. Segment Information in the notes to the unaudited condensed consolidated financial statements for information on our segments after the Merger.

This MD&A discusses the financial condition and results of operations of the Company as of and for the three and nine months ended September 30, 2023, which includes Neenah.

During the three month period ending September 30, 2022, the Company became aware of a cyber attack that had been made against certain systems within the Company’s network environment. The attack temporarily affected operations and caused delays in execution of sales transactions at some locations. In addition, the Company incurred financial costs to investigate and remediate the incident, some of which are expected to be mitigated by insurance. During the incident, the attackers accessed and exfiltrated Company data, including some personally identifying information of certain Company employees. The Company believes it has contained the incident, which only affected certain systems, and it has restored operations and notified affected individuals. The Company has put in place remediation measures designed to help prevent future similar attacks, and has proactively undertaken to implement certain other enhancements to its security system.

Liquidity & Debt Overview

As of September 30, 2023, the Company had $1,738.5 million of total debt, $84.7 million of cash, and undrawn capacity on its $600.0 million revolving line of credit facility (the "Revolving Facility") of $329.1 million. Per the terms of the Company's amended credit agreement (the "Amended Credit Agreement"), net leverage was 4.2x at the end of the third quarter, versus a current maximum covenant ratio of 4.75x. The Company’s nearest debt maturity is our 6.875% senior unsecured notes which are due in 2026. Refer to "Liquidity and Capital Resources" section for additional detail.

SUMMARY

(in millions, except per share amounts)

Three Months Ended September 30, 2023 2022 Percent of Net Sales 2023 2022 Nine Months Ended September 30, 2023 2022 Percent of Net Sales 2023 2022
Net sales $498.2 $551.5 100.0% 100.0% $1,573.7 $1,112.5 100.0% 100.0%
Gross profit 86.7 96.1 17.4% 17.4% 269.9 218.6 17.2% 19.6%
Restructuring & impairment expense 16.3 1.8 3.3% 0.3% 17.6 17.3 1.1% 1.6%
Operating loss (419.9) (31.6) (84.3)% (5.7)% (411.7) (42.3) (26.2)% (3.8)%
Interest expense 16.8 14.9 3.4% 2.7% 48.8 43.7 3.1% 3.9%
Net loss from continuing operations $(464.3) $(34.0) (93.2)% (6.2)% $(494.1) $(66.4) (31.4)% (6.0)%
Diluted loss per share from continuing operations $(8.50) $(0.65) $(9.06) $(1.74)
Cash provided by operations $32.3 $(19.0) $37.8 $(44.6)
Capital spending $7.4 $9.3 $49.4 $27.1

39

RESULTS OF OPERATIONS

Comparison of the Three Months Ended September 30, 2023 and 2022

Net Sales

The following table presents net sales by segment for the three months ended September 30, 2023 and 2022 (in millions):

Three Months Ended September 30, 2023 September 30, 2022 Change Percent Change
Advanced Technical Materials $393.8 $426.1 $(32.3) (7.6)%
Fiber-Based Solutions 104.4 125.4 (21.0) (16.7)%
Total $498.2 $551.5 $(53.3) (9.7)%

Consolidated net sales of $498.2 million during the three months ended September 30, 2023 decreased $53.3 million or 9.7%, compared to the prior-year quarter.

ATM segment net sales of $393.8 million during the three months ended September 30, 2023 decreased $32.3 million, or 7.6%, compared to the prior-year quarter. ATM sales decline reflected lower volume partly offset by higher selling price and favorable currency translation. Lower volumes across the segment reflect increased customer caution in the current uncertain economic environment, as well as impacts from seasonal slowing, particularly in Europe. Healthcare was a top performer, with double-digit growth for the quarter.

FBS segment net sales of $104.4 million during the three months ended September 30, 2023 decreased $21.0 million, or 16.7%, compared to the prior-year quarter, and are now comprised solely of Packaging and Specialty Papers. The FBS sales decline reflected lower volume compared to prior year when significant industry-wide customer inventory builds occurred. Lower demand for premium business papers and packaging, along with continued customer destocking, offset benefits from increased sales of consumer papers and higher selling prices.

Gross Profit

The following table presents gross profit for the three months ended September 30, 2023 and 2022 (in millions):

Three Months Ended September 30, 2023 September 30, 2022 Change Percent Change 2023 Percent of Net Sales 2022
Net sales $498.2 $551.5 $(53.3) (9.7)% 100.0% 100.0%
Cost of products sold 411.5 455.4 (43.9) (9.6)% 82.6% 82.6%
Gross profit $86.7 $96.1 $(9.4) (9.8)% 17.4% 17.4%

Gross profit of $86.7 million during the three months ended September 30, 2023 decreased $9.4 million, or 9.8%, compared to the prior-year quarter. The decrease in gross profit reflected lower volume impacts, and associated manufacturing inefficiencies and fixed cost absorption, partly offset by benefits of selling prices net of input costs and favorable currency translation. The Company monitors and continues to adjust staffing levels of manufacturing labor relative to volumes.

Non-manufacturing Expenses

The following table presents non-manufacturing expenses for the three months ended September 30, 2023 and 2022 (in millions):

Three Months Ended September 30, 2023 September 30, 2022 Change Percent Change 2023 Percent of Net Sales 2022
Selling expense $20.5 $19.1 $1.4 7.3% 4.1% 3.5%
Research expense 5.4 5.9 (0.5) (8.5)% 1.1% 1.1%
General expense 63.4 100.9 (37.5) (37.2)% 12.8% 18.3%
Non-manufacturing expenses $89.3 $125.9 $(36.6) (29.1)% 17.9% 22.8%

Non-manufacturing expenses of $89.3 million during the three months ended September 30, 2023 decreased $36.6 million, or 29.1%, compared to the prior-year quarter. The decrease is primarily due to higher costs in 2022 including direct and indirect merger acquisition and integration costs of $46.7 million, and $5.7 million to resolve the cybersecurity incident in the prior year quarter, partially offset by $17.3 million of costs related to the merger, planned divestiture of the EP business and financing fees in the current quarter.

Restructuring and Other Impairment Expense

The following table presents restructuring and other impairment expense for the three months ended September 30, 2023 and 2022 (in millions):

Three Months Ended September 30, 2023 September 30, 2022 Change Percent of Net Sales 2023 2022
Advanced Technical Materials $6.8 $0.9 $5.9 0.5% 0.2%
Fiber-Based Solutions 9.5 0.1 9.4 2.9% 0.1%
Unallocated expenses — 0.8 (0.8)
Total $16.3 $1.8 $14.5 1.0% 0.3%

The Company incurred total restructuring and other impairment expense of $16.3 million and $1.8 million in the three months ended September 30, 2023 and 2022, respectively. In the current year period, restructuring and other impairment expense in the ATM segment was driven by plans to close two facilities as a result of decisions to exit certain end markets, ongoing manufacturing optimization efforts and facilities closed in prior years. In the FBS segment, restructuring and impairment expense in the current year period was driven by impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility.

In the prior year period, restructuring and impairment expense in the ATM segment was related to facilities closed in prior years.

Restructuring and impairment costs related to the Merger are included in corporate expenses as other unallocated items as these costs are not included in management's evaluation of the segments' performance. Unallocated restructuring expenses for the three months ended September 30, 2022 included $0.8 million related to the modification of leases resulting from the Merger.

Operating Loss

The following table presents operating profit/(loss) by segment for the three months ended September 30, 2023 and 2022 (in millions):

Three Months Ended September 30, 2023 September 30, 2022 Change Percent Change 2023 Return on Net Sales 2022
Advanced Technical Materials $(378.8) $31.5 $(410.3) (1,302.5)% (96.2)% 7.4%
Fiber-Based Solutions (4.4) 10.3 (14.7) (142.7)% (4.2)% 8.2%
Unallocated expenses (36.7) (73.4) 36.7 (50.0)%
Total $(419.9) $(31.6) $(388.3) 1,228.8% (84.3)% (5.7)%

Operating loss of $419.9 million during the three months ended September 30, 2023, increased $388.3 million, or 1,228.8%, compared to the prior year period. Both periods included unusual costs as previously described and related to an impairment charge in 2023 and the merger in 2022.

In the ATM segment, operating loss was $378.8 million during the three months ended September 30, 2023 reflecting a $410.3 million, or 1,302.5% change, compared to the prior year period primarily due to the goodwill impairment recorded of $401.0 million. For more information on the goodwill impairment, see Note 7. Goodwill. In the FBS segment, operating loss of $4.4 million during the three months ended September 30, 2023 decreased $14.7 million, or 142.7%, compared to the prior year period. In both segments, operating profit reflects lower volumes offsetting favorable impacts of net selling price/input cost increases. Unallocated expenses of $36.7 million during the three months ended September 30, 2023 decreased $36.7 million, or 50.0%, compared to the prior year period primarily due to the merger and integration related costs incurred in the prior year period.

Interest Expense

Interest expense of $16.8 million during the three months ended September 30, 2023 increased $1.9 million, or 12.8%, compared to the prior year period. Interest expense increased primarily due to higher average interest rates.

Other Income (Expense), Net

Other income (expense), net was $(0.3) million during the three months ended September 30, 2023, compared to the prior year period income of $1.4 million. The net change was primarily driven by losses on foreign exchange contracts.

Income Taxes

A $27.3 million income tax expense in the three months ended September 30, 2023 resulted in an effective tax rate of (6.2)% compared with 24.6% in the prior year period. The net change was primarily due to a $32.0 million valuation allowance expense in the current period.

Net Loss and Net Loss per Share

Net loss during the three months ended September 30, 2023 was $464.3 million, or $8.50 per diluted share, compared with net loss of $34.0 million, or $0.65 per diluted share, during the prior-year quarter.

RESULTS OF OPERATIONS

Comparison of the Nine Months Ended September 30, 2023 and 2022

Net Sales

The following table presents net sales by segment (in millions):

Nine Months Ended September 30, 2023 2022 Change Percent Change
Advanced Technical Materials $1,248.0 $987.1 $260.9 26.4%
Fiber-Based Solutions 325.7 125.4 200.3 159.7%
Total $1,573.7 $1,112.5 $461.2 41.5%

Consolidated net sales of $1,573.7 million during the nine months ended September 30, 2023 increased $461.2 million, or 41.5%, compared to the prior year period.

ATM segment net sales of $1,248.0 million during the nine months ended September 30, 2023 increased $260.9 million, or 26.4%, compared to the prior year period. ATM sales growth was due to the addition of the Neenah operations. Price increases across the product lines, in response to higher input costs were offset by volume declines. The decreased volume was caused by customer de-stocking trends and an uncertain macro environment.

FBS segment net sales of $325.7 million during the nine months ended September 30, 2023 increased $200.3 million, or 159.7%, compared to the prior year period. FBS sales growth was due to the addition of the Neenah operations. Consistent with trends in ATM, price increases across the FBS product lines in response to higher input costs were offset by volume declines which were mostly driven by customer de-stocking in packaging and specialty paper.

Gross Profit

The following table presents gross profit (in millions):

Nine Months Ended September 30, 2023 2022 Change Percent Change 2023 Percent of Net Sales 2022
Net sales $1,573.7 $1,112.5 $461.2 41.5% 100.0% 100.0%
Cost of products sold 1,303.8 893.9 409.9 45.9% 82.8% 80.4%
Gross profit $269.9 $218.6 $51.3 23.5% 17.2% 19.6%

Gross profit of $269.9 million during the nine months ended September 30, 2023 increased $51.3 million, or 23.5%, compared to the prior year period. The increase in gross profit reflected the addition of the Neenah operations. While price increases more than offset higher input costs across both segments, lower volume impacts, along with manufacturing inefficiencies negatively impacted results. The Company addressed production performance across several facilities, primarily in FBS, which have been impacted by high manufacturing labor turnover and resulted in less efficient operations. Profitability in both segments was also impacted by staffing levels of manufacturing labor relative to volumes, and the Company has adjusted staffing levels to be in line with demand requirements.

Non-manufacturing Expenses

The following table presents non-manufacturing expenses (in millions):

Nine Months Ended September 30, 2023 2022 Change Percent Change 2023 Percent of Net Sales 2022
Selling expense $60.6 $41.1 $19.5 47.4% 3.9% 3.7%
Research and development expense 16.6 12.7 3.9 30.7% 1.1% 1.1%
General expense 185.8 189.8 (4.0) (2.1)% 11.8% 17.1%
Non-manufacturing expenses $263.0 $243.6 $19.4 8.0% 16.8% 21.9%

Non-manufacturing expenses of $263.0 million during the nine months ended September 30, 2023 increased by $19.4 million, or 8.0%, compared to the prior year period. The increase is primarily due to the addition of Neenah's non-manufacturing expenses which includes an increase in amortization expenses related to Neenah's intangible assets, partially offset by lower integration related expenses in 2023.

Restructuring and Other Impairment Expense

The following table presents restructuring and other impairment expense by segment (in millions):

Nine Months Ended September 30, 2023 2022 Change Percent of Net Sales 2023 2022
Advanced Technical Materials $8.0 $14.9 $(6.9) 0.6% 1.5%
Fiber-Based Solutions 9.6 1.6 8.0 2.9% 1.3%
Unallocated expenses — 0.8 (0.8)
Total $17.6 $17.3 $0.3 1.1% 1.6%

The Company incurred total restructuring and other impairment expense of $17.6 million in the nine months ended September 30, 2023 compared with $17.3 million in the prior year period. In the current year period, restructuring and other impairment expense in the ATM segment was primarily comprised of fixed asset and certain other asset impairment for our announced planned facility closures and facilities closed in prior years. Restructuring and other impairment expense in the FBS segment was primarily driven by impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility.

The Company incurred total restructuring and other impairment expense of $17.3 million in the nine months ended September 30, 2022. In the ATM segment, restructuring and impairment expense for the prior year period were primarily related to the impairment of certain assets in conjunction with the divestiture of a portion of the legacy SWM ATM segment serving the industrials end market. These assets were sold during the third quarter of 2022 for net proceeds of $4.6 million and a loss of $0.4 million. In the prior-year period restructuring and other impairment expense in the FBS segment included $1.5 million primarily related to closed facilities.

Operating Loss

The following table presents operating profit (loss) by segment (in millions):

Nine Months Ended September 30, 2023 2022 Change Percent Change 2023 Return on Net Sales 2022
Advanced Technical Materials $(306.1) $71.2 $(377.3) (529.9)% (24.5)% 7.2%
Fiber-Based Solutions (1.1) 9.1 (10.2) (112.1)% (0.3)% 7.3%
Unallocated expenses (104.5) (122.6) (18.1) (14.8)%
Total $(411.7) $(42.3) $(369.4) 873.3% (26.2)% (3.8)%

44

Operating loss of $411.7 million during the nine months ended September 30, 2023 increased $369.4 million, or 873.3%, compared to the prior year period.

In the ATM segment, operating loss was $306.1 million during the nine months ended September 30, 2023 reflecting a $377.3 million, or 529.9% change, compared to the prior year period operating profit primarily attributed to a goodwill impairment recorded of $401.0 million. In the FBS segment, operating loss of $1.1 million during the nine months ended September 30, 2023 decreased $10.2 million, or 112.1%, compared to the prior year period. In both segments, operating profit reflects the addition of the Neenah operations and the benefit of price increases more than offsetting higher input costs, which were offset by declining volumes across most products. The decline in FBS operating profits was largely driven by manufacturing inefficiencies at several facilities, as well as intangible asset amortization expenses associated with the Merger, and $9.5 million of costs related to the impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility. Unallocated expenses of $104.5 million during the nine months ended September 30, 2023 decreased $18.1 million, or 14.8% compared to the prior year period primarily due to the merger and integration related costs incurred in the prior year period, offset by the addition of Neenah's unallocated expenses and integration and divestiture related costs in the current period.

Interest Expense

Interest expense of $48.8 million during the nine months ended September 30, 2023 increased $5.1 million, or 11.7%, compared to the prior year period. Interest expense increased primarily due to incremental debt related to the Merger, the incremental expense of assuming Neenah's debt, and higher average interest rates.

Other Income (Expense), Net

Other income (expense), net of $3.6 million during the nine months ended September 30, 2023 decreased $8.8 million, or 169.2% compared to the prior year period. The net change was primarily driven by the gain on the sale of equipment at the Winkler facility in the prior period, partially offset by legal and tax settlement expenses in the current period.

Income Taxes

A $30.0 million income tax expense in the nine months ended September 30, 2023 resulted in an effective tax rate of (6.5)% compared with 17.8% in the prior year period. The net change was primarily due to a $40.0 million valuation allowance expense in the current period.

Net Income (Loss) and Net Income (Loss) per Share

Net loss during the nine months ended September 30, 2023 was $467.2 million, or $8.57 per diluted share, compared to net income of $9.1 million, or $0.25 per diluted share, during the prior year period.

LIQUIDITY AND CAPITAL RESOURCES

A major factor in our liquidity and capital resource planning is our generation of cash flow from operations, which is sensitive to changes in the mix of products sold, volume and pricing of our products, as well as changes in our production volumes, costs and working capital. Our liquidity is supplemented by funds available under our Revolving Facility with a syndicate of banks that is used as either operating conditions or strategic opportunities warrant.

Cash Requirements

As of September 30, 2023, $59.5 million of the Company's $84.7 million of cash and cash equivalents was held by foreign subsidiaries. We believe our sources of liquidity and capital, including cash on-hand, cash generated from operations and our existing credit facilities, will be sufficient to finance our continued operations, our current and long-term growth plan, and dividend payments.

Cash Provided by (Used in) Operating Activities

Net cash provided by operating activities was $37.8 million during the nine months ended September 30, 2023 compared to net cash used of $44.6 million during the prior year period. Compared to the prior year period, cash inflows from working capital increased by $65.9 million, due to a reduction in inventories in the current period.

Working Capital

As of September 30, 2023, the Company had net working capital of $546.3 million, including cash and cash equivalents of $84.7 million, compared to net working capital of $538.5 million, including cash and cash equivalents of $101.1 million as of December 31, 2022. During the nine months ended September 30, 2023, net changes in operating working capital resulted in a cash inflow of $13.4 million, an increase from $79.3 million of outflows during the prior year period largely due to decreases in receivables and inventory.

Cash Used in Investing Activities

Cash used in investing activities during the nine months ended September 30, 2023 was $49.4 million, compared to cash outflows of $453.4 million during the prior year period, which were mainly attributable to capital spending, and reflected the addition of the Neenah operations and repayment of Neenah's outstanding debt. Within investing cash flows, capital spending was $49.4 million compared to $27.1 million in the prior year period, reflecting the addition of Neenah operations and capacity expansion projects for filtration and release liner products. Investing cash flows in the prior year period also included $35.8 million inflow from cash received in the settlement of cross-currency swaps contracts.

Cash Provided by (Used in) Financing Activities

Cash used in financing activities during the nine months ended September 30, 2023 was $13.2 million, compared to cash provided of $461.5 million during the prior year period. During the nine months ended September 30, 2023, financing activities primarily consisted of $180.0 million of borrowings under the revolving credit facility, $49.8 million of dividends paid to the Company's stockholders, and payments on our long-term debt of $134.2 million.

During the prior year period, financing activities primarily consisted of $179.5 million of payments on our long-term debt, $720.4 million of proceeds from borrowings under the revolving credit facility, the proceeds of which were primarily used to repay Neenah's debt upon consummation of the Merger, $50.1 million in cash paid for dividends paid to the Company's stockholders, and $22.6 million of payments for debt issuance costs associated with the amendment of our Credit Agreement as discussed in Note 10. Debt of the notes to the unaudited condensed consolidated financial statements.

The Company presently believes the sources of liquidity discussed above are sufficient to meet our anticipated funding needs for the foreseeable future.

Dividends and Share Repurchases

On November 8, 2023, we announced a cash dividend of $0.10 per share payable on December 15, 2023 to stockholders of record as of November 24, 2023. The covenants contained in our Indenture and amended Credit Agreement require that we maintain certain financial ratios as disclosed in Note 10. Debt of the notes to the unaudited condensed consolidated financial statements, none of which under normal business conditions materially limit our ability to pay such dividends. We will continue to assess our dividend policy in light of our overall strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.

During the nine months ended September 30, 2023, the company repurchased $7.0 million of outstanding shares of which $4.4 million were repurchased as part of the share buyback program authorized by the Board of Directors in August 2023. The Company intends to repurchase shares periodically and opportunistically to offset dilution due to stock compensation. During the quarter ended September 30, 2022, the company repurchased $6.4 million of outstanding shares.

Debt Instruments and Related Covenants

The following table presents activity related to our debt instruments for the nine months ended September 30, 2023 and 2022 (in millions):

2023 Nine Months Ended September 30, 2022
Proceeds from long-term debt $180.0 $720.4
Payments on long-term debt (134.2) (179.5)
Net proceeds from borrowings $45.8 $540.9

Net proceeds from borrowings were $45.8 million during the nine months ended September 30, 2023, compared to net repayments of $540.9 million during the prior year period.

On June 5, 2023, the Company amended its Credit Agreement to replace LIBOR-based rates with term-SOFR for the Term Loan B Facility. Effective July 1, 2023, borrowings under the Term Loan B Facility in U.S. dollar will bear interest equal to a forward-looking term rate based on Term SOFR (subject to a minimum floor of 0.75%) plus 2.75%. Borrowings under the Term Loan B Facility in Euros will bear interest equal to EURIBOR (subject to a minimum floor of 0.00%) plus 3.75%.

Unused borrowing capacity under the amended Credit Agreement was $329.1 million as of September 30, 2023.

The Company was in compliance with all of its covenants under the Indenture and amended Credit Agreement at September 30, 2023. With the current level of borrowing and forecasted results, we expect to remain in compliance with financial covenants under the amended Credit Agreement.

Our total debt to capital ratios, as calculated under the amended Credit Agreement, at September 30, 2023 and December 31, 2022 were 72.1% and 58.9%, respectively.

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported. There have been no material changes in our critical accounting policies and estimates since December 31, 2022 other than the below item related to goodwill.

Effective July 1, 2023, and as a result of our ongoing integration efforts, we identified a change in our operating segments. While the ATM reportable segment remains as an aggregation of the Company’s highly engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwoven products, the segment was disaggregated into five reporting units due to changes in segment level management and the related internal reporting of operating results (refer to Note 15. Segment Information for additional information on our segments).

Further, during 2023, the sustained impact of macro-economic conditions, an increasingly global competitive environment, moderation in certain projected volume expectations, and a sustained decrease in our share price contributed to the decline in reporting unit fair value. Additionally, management completed a long term financial model, aligning with the new reporting unit structure during the third quarter. That plan’s forecast reflects the higher relative allocation of corporate overhead costs to continuing operations as a result of the proposed sale of our EP business.

The fair value of a reporting unit is based on an income approach, utilizing estimated future cash flows discounted at a rate commensurate with the risk involved and considers significant assumptions including projections of future performance, specifically our ability to sustain and grow market share at forecasted margins and significant assumptions around the rate a market participant would use to discount those cash flows. Changes in these assumptions can have a significant impact on the assessment of fair value. While the fair value of each reporting unit was ultimately estimated using the income approach, management also evaluated fair value under the market approach to evaluate the reasonableness of the estimated fair values.

For further information about our critical accounting policies, please see the discussion of critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2022 in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates.”

Off-Balance Sheet Arrangements

As of September 30, 2023, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the incurrence of additional debt and expected maturities of the Company’s debt obligations, the adequacy of our sources of liquidity and capital, acquisition integration and growth prospects (including international growth), the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, impacts and timing of our ongoing operational excellence and other cost-reduction and cost-optimization initiatives, any lingering impact of the COVID-19 pandemic on our operations, profitability, and cash flow, the expected benefits and accretion of the Neenah merger and Scapa acquisition and integration and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.

These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this report. These risks include, among other things, those set forth in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2022, the Risk Factors set forth in the section entitled "Risk Factors" at Part II - Item 1A hereof, as well as the following factors:

  • Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
  • Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ, including the pending Engineered Papers Transaction;
  • Adverse changes in the filtration, release liners, protective solutions, industrials and healthcare sectors impacting key ATM segment customers;
  • Changes in the source and intensity of competition in our commercial end-markets: filtration, protective solutions, release liners, healthcare, and industrials for ATM, and packaging and specialty papers for FBS;
  • Adverse changes in sales or production volumes, pricing and/or manufacturing costs in our ATM or FBS operating segments;
  • Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
  • Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
  • Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
  • Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
  • Business disruptions from the Merger that will harm the Company's business, including current plans and operations;
  • The possibility that Mativ may be unable to successfully integrate Neenah's operations with those of Mativ and achieve expected synergies and operating efficiencies within the expected time-frames or at all;
  • Potential adverse reactions or changes to business relationships resulting from the Merger, including as it relates to the Company's ability to successfully renew existing client contracts on favorable terms or at all and obtain new clients;
  • Our ability to attract and retain key personnel, including as a result of the Merger, labor shortages, labor strikes, stoppages or other disruptions;
  • The substantial indebtedness Mativ has incurred and assumed in connection with the Merger and the need to generate sufficient cash flows to service and repay such debt;
  • Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro and Real) and on interest rates;
  • A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
  • Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
  • Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;
  • Uncertainty as to the long-term value of the common stock of Mativ, including the dilution caused by Mativ’s issuance of additional shares of its common stock in connection with the Merger;
  • Changes in employment, wage and hour laws and regulations in the U.S., France and elsewhere, including the loi de Securisation de l'emploi in France, unionization rules and regulations by the National Labor Relations Board in the U.S., equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
  • The impact of tariffs, and the imposition of any future additional tariffs and other trade barriers, and the effects of retaliatory trade measures;
  • Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
  • Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
  • International conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
  • Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
  • The continued evolution of COVID-19, or new public health crises that may arise in the future, could have adverse and disparate impacts on the Company, our employees and customers;
  • The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs, including those in Brazil, France and Germany;
  • Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, particularly our sales of combustible products business within the tobacco industry, as well as our ability to achieve our broader ESG goals and objectives;
  • Costs and timing of implementation of any upgrades or changes to our information technology systems;
  • Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
  • The impact of cybersecurity risks related to breaches of security pertaining to sensitive Company, customer, or vendor information, as well as breaches in the technology that manages operations and other business processes; and
  • Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.

All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data.

Market risk

As filed, 325 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our market risk exposure at September 30, 2023 is consistent with, and not materially different than, the market risk and discussion of exposure presented under the caption “Quantitative and Qualitative Disclosures about Market Risk” in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2022.

Controls and procedures

As filed, 1,208 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We currently have in place systems relating to disclosure controls and procedures designed to ensure the timely recording, processing, summarizing and reporting of information required to be disclosed in periodic reports under the Securities Exchange Act of 1934, as amended. These disclosure controls and procedures include those designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions about required disclosure. Upon completing our review and evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2023, our Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures were effective as of September 30, 2023.

Changes in Internal Control Over Financial Reporting

No changes in our internal control over financial reporting were identified as having occurred in the fiscal quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 633 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, "Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-07-01 to 2023-09-30$498.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2023-01-01 to 2023-09-30$1.57bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-07-01 to 2023-09-30$411.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2023-01-01 to 2023-09-30$1.30bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-07-01 to 2023-09-30$86.7mus-gaap:GrossProfit
Gross profit9 months2023-01-01 to 2023-09-30$269.9mus-gaap:GrossProfit
Research and development3 months2023-07-01 to 2023-09-30$5.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2023-01-01 to 2023-09-30$16.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2023-07-01 to 2023-09-30−$419.9mus-gaap:OperatingIncomeLoss
Operating income9 months2023-01-01 to 2023-09-30−$411.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-07-01 to 2023-09-30$16.8mus-gaap:InterestExpense
Interest expense9 months2023-01-01 to 2023-09-30$48.8mus-gaap:InterestExpense
Income tax3 months2023-07-01 to 2023-09-30$27.3mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2023-01-01 to 2023-09-30$30.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-07-01 to 2023-09-30−$455.0mus-gaap:NetIncomeLoss
Net income9 months2023-01-01 to 2023-09-30−$467.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-07-01 to 2023-09-30−$8.33us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2023-01-01 to 2023-09-30−$8.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-07-01 to 2023-09-30−$8.33us-gaap:EarningsPerShareBasic
Basic EPS9 months2023-01-01 to 2023-09-30−$8.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-07-01 to 2023-09-3054,659,100 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2023-01-01 to 2023-09-3054,600,100 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2023-01-01 to 2023-09-30$52.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2023-01-01 to 2023-09-30$49.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2023-01-01 to 2023-09-30$49.8mus-gaap:PaymentsOfDividends
Share repurchases9 months2023-01-01 to 2023-09-30$7.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-09-30$84.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-09-30$914.4mus-gaap:AssetsCurrent
Total assetsAt period end2023-09-30$3.12bnus-gaap:Assets
Current liabilitiesAt period end2023-09-30$403.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-09-30$2.44bnus-gaap:Liabilities
Long-term debtAt period end2023-09-30$1.70bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-09-30$34.5mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-09-30$673.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001000623-23-000062. Last ingested by Listed: Nov 5, 2026, 16:53 ET. Listed shows no prices and gives no investment advice.